Dr. Stoll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9735 Wilshire Blvd
Ste 418
Beverly Hills, CA 90212Phone+1 310-273-6558Fax+1 310-273-3570
Education & Training
Vanderbilt University Medical CenterResidency, Dermatology, 1981 - 1984
USPHS HospitalInternal Medicine, 1980 - 1981
Vanderbilt University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1981 - 2025
NY State Medical License 1987 - 1994
NJ State Medical License 1988 - 1991
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NexTech Practice 2013 EHR, NexTech Systems, Inc., 2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 13 citationsHuman Urinary Epidermal Growth Factor Excretion: Age, Sex, and Race DependenceDavid M. Stoll, Lloyd E. King, Larry McNEIL, David N. Orth
The Journal of Clinical Endocrinology and Metabolism. 1988-08-01 - 27 citationsAssociation of bullous pemphigoid with systemic lupus erythematosusDavid M. Stoll, Lloyd E. King
Archives of Dermatology. 1984-03-01 - 12 citationsTreatment of cutaneous pseudolymphoma with hydroxychloroquineDavid M. Stoll
Journal of the American Academy of Dermatology. 1983-05-01
Professional Memberships
- Fellow
Other Languages
- Spanish, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
